A Dose-escalation Study in Subjects With Pulmonary Arterial Hypertension (PAH)

Clinical trial NCT03177603 · COMPLETED

Trial details

NCT number: NCT03177603
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Hypertension, Pulmonary

Start date: 2018-02-21
Primary completion: 2019-05-07
Enrollment: 23

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.